Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EWG Supports Nano-Engineered Mineral Sunscreens In 2013 Report

This article was originally published in The Tan Sheet

Executive Summary

Sunscreens containing zinc oxide and titanium dioxide nanoparticles rate relatively highly in the Environmental Working Group’s annual Sunscreen Guide, though the advocacy group says greater transparency is needed regarding products with nano-engineered ingredients.

You may also be interested in...



OTC Monograph System Needs Transparency, Communication – PCPC

While FDA’s OTC drug monograph system is an “appropriate and rational framework” for regulating cosmetic-drug products, greater transparency and more regular communication with industry are needed, according to Personal Care Products Council executive Elizabeth Anderson.

OTC Monograph System Needs Transparency, Communication – PCPC

While FDA’s OTC drug monograph system is an “appropriate and rational framework” for regulating cosmetic-drug products, greater transparency and more regular communication with industry are needed, according to Personal Care Products Council executive Elizabeth Anderson.

Badger Reformulating Sunscreens For Babies, Kids As Recall Unfolds

Testing shows the products are contaminated with potentially infectious microorganisms: Pseudomonas aeruginosa, Candida parapsilosis and Acremonium fungi. Badger says it is moving to a different contract manufacturer “to eliminate any processing factors that may have contributed to this situation.”

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel